Pain Stories
Doctors urge better pain care for troops
May 7, 2007
They call it the coming tsunami, veterans returning from Iraq who will suffer chronic pain years from now. Get ready, military doctors are warning pain specialists--even as they hope that slowly improving battlefield pain control may stem the tide. StoryNarcotic
Narcotic lollipops: are patients abusing them?
May 7, 2007
Questions are raised over how a potent painkiller has been marketed. As many as 80 percent of the 400,000 prescriptions written each year for Actiq and its generic versions go to sufferers of chronic, noncancer pain. There are no large, completely objective studies of Actiq's effectiveness in these patients, but the drug's active ingredient, fentanyl, has been used widely for more than 40 years. Story
Alternative relief for carpel tunnel, tendinitis, tennis elbow and arthritis
May 7, 2007
Foundation for Magnetic Science reports remarkable results on Biomagnetic therapy for Carpel Tunnel, Tendinitis and arthritis of the wrists and hand. Story
FDA causes unnecessary scare about common painkillers
April 24, 2007
The U.S. Food and Drug Administration (FDA) has caused an unnecessary scare about some pain relievers by adding a warning to drugs that are safe, says Curt Furberg, M.D., Ph.D., from Wake Forest University School of Medicine. At the same time, he says the agency has failed to recognize the harm of a pain reliever that should be taken off the market. Story
Back-pain treatment scrutinized
April 19, 2007
While some patients report near-miraculous relief from DRX 9000 machines, the companies that make them and the chiropractors who buy them are coming under increasing scrutiny from local district attorneys and federal officials for fraudulent advertising and unproven claims of effectiveness. Story
Vioxx successor fails to win approval from FDA panel
April 12, 2007
Merck & Co. Inc. failed on Thursday to win experts' backing for selling its Vioxx successor drug Arcoxia, reflecting a hardened attitude toward drug safety and pharmaceutical marketing. The nearly unanimous thumbs-down vote by the U.S. Food and Drug Administration's arthritis advisory committee is not binding. But its recommendation against a drug already approved by several other countries. Story
Managing fibromyalgia: the potential role of a living foods diet
April 1, 2007
Dietary intervention is a potential alternative therapy for fibromyalgia. While the etiology and pathophysiology are inconclusive, fibromyalgia may be an oxidative stress disorder, and some affected by this disorder have found that a high antioxidant, "living food" diet helpful in symptom management. Story
|
